藥物成份

共有 21645 個藥物成份

Anti-human IgG serum (goat) Titer: 3.5 unit Titer of antiserum is measured by Becker method. 1 mg/ml of Becker unit shall be 1 unit of titer.

• 關聯藥證數量: 1

Anti-human IgG: 18 mL

• 關聯藥證數量: 1

Anti-human IgM (Goat): 18 mL

• 關聯藥證數量: 1

Anti-phenobarbital monoclonal antibody (mouse).

• 關聯藥證數量: 1

Anti-prealbuminantibody coated particle Buffer Microbial inhibitros Polyethylene glycol Buffer Surfactant Microbial inhibitors

• 關聯藥證數量: 1

Anti-progesterone antibody coated tubes: 2x 50 tubes.125I-labeled progesterone: one 55 ml vial. The vial contains 185 kBq, at the date of manufacture, of 125I labeled progesterone with buffer and proteins.Standards: six 0.5 ml vials.The standard vials contain concentration of progesterone for a standard range from 0 to 60 ng/ml in human serum with sodium azide (0.1%).Control: one 0.5 ml vial. The vial contains progesterone in human serum with sodium azide(0.1%).

• 關聯藥證數量: 1

Anti-prolactin monoclonal antibody coated tubes: 2 x 50 tubes 125I-labeled monoclonal antibody: one 55 mL vial The vial contains 370 kBq, at the date of manufacture, of 125I-labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide (<0.1%) and a dye.Calibrators: five vials + one 5 mL zero calibrator vialThe calibrator vials contain from 0 to 180 ng/mL of human prolactin in horse serum and sodium azide (<0.1%). The exact concentration is indicated on each vial.Control sera: two vialsThe vials contain human prolactin lyophilized in human serum. Wash solution (20X): one 50 mL vial

• 關聯藥證數量: 1

Anti-prolactin monoclonal antibody coated tubes: 2x 50 tubes.125I-labeled monoclonal antibody: one 55 ml vial. The vial contains 370 kBq, at the date of manufacture, of 125I labeled immunoglobulins in buffer containing bovine serum albumin, sodium azide (< 0.1%) and a dye.Standards: five vials (lyophilized) + one 5 ml zero standard vial. The standard vials contain from 0 to 180 ng/ml of human prolactin in horse serum and sodium azide (0.1%).Control sera: two vials (lyophilized). The vials contain human prolactin lyophilized in human serum.Wash solution (20x): one 50 ml vial.

• 關聯藥證數量: 1

Anti-theophylline monoclonal antibody (mouse) in buffer, pH7.5, with stabilizer and preservative.

• 關聯藥證數量: 1

Anti-vancomycin monoclonal antibody (mouse) in buffer, pH6.5, with stabilizer and preservative.

• 關聯藥證數量: 1

Antibodies from heterohybridoma MS201 and MS26.

• 關聯藥證數量: 1

Antibodies from：Birma-1, ES-4, ES-15.

• 關聯藥證數量: 1

Antibody Buffer (56 mL): Anti-HbA1c Antibodies (sheep) >0.5 mg/mLMES (2-morpholino-ethanesulfonic acid) Buffer (pH6.2) 0.05 mol/LPolyhapten Buffer (12 mL): HbA1c Polyhapten ≧20μg/mLHemoglobin Buffer (102 mL): Phosphate Buffer (pH 7.4) 0.02 mol/LCALIBRATOR CONSTITUENTS Hemolysate (human and sheep) 0.9% tetradecyltrimethylammonium bromide HEMOLYZING REAGENT (1000 mL)Tetradecyltrimethylammonium bromide: 9 g/L

• 關聯藥證數量: 1

Antibody Control (1.5ml). Lyophilized goat anti-rabbit serum containing a preservative.

• 關聯藥證數量: 1

Antibody From Hybridoma cell lines 16H8, 053A.714, 055A.305.

• 關聯藥證數量: 1

Antibody Reagent Contains: monoclonal anti-digoxin antibody in a buffer solution with sodium azide as a preservative. Microparticles Reagent Contains: digoxin coated microparticles suspension in an aqueous solution with sodium azide as a preservative. Calibrators: DRI Digoxin Negative Calibrator 1 x 5 mL (Contains 5 mL buffer solution with sodium azide as a preservative); DRI Digoxin 0.5 ng/mL Calibrator 1 x 2 mL (Contains 0.5 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 1.0 ng/mL Calibrator 1 x 2 mL (Contains 1.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 2.0 ng/mL Calibrator 1 x 2 mL (Contains 2.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 3.0 ng/mL Calibrator 1 x 2 mL (Contains 3.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative); DRI Digoxin 5.0 ng/mL Calibrator 1 x 2 mL (Contains 5.0 ng/mL Digoxin in buffer solution with sodium azide as a preservative).

• 關聯藥證數量: 1

Antibody latex: 2.5% w/v HbA1 c-specific mouse monoclonal antibody-latex in 10mM glycine buffer, 16% w/v non-reactive ingredients.\nAgglutinator: 0.005% w/v poly (aspartic acid) polymer, HbA 1c hapten in 20mM sodium citrate buffer containing 0.1% w/v bovine serum albumin, 1% w/v non-reactive ingredients.\nBuffer Solution: 8.1% w/v lithium thiocyanate, 0.01% digitonin in 200mM glycine buffer\nOxidant: 1.5% w/v potassium ferricyanide in water with 21% w/v non-reactive ingredients.

• 關聯藥證數量: 1

Antibody monospecific for human Transferrin (Goat): 18 mL

• 關聯藥證數量: 1

Antibody-coated microtiter plate with 96 wells.\nLyophilized CEA standards containing; 0, 3, 12, 30, 60, and 120ng/ml CEA. 1 set.\nEnzyme Conjugate Reagent\nTMB Reagent (One-Step)\nStop Solution (1N HCl)\n

• 關聯藥證數量: 1

Antibody-colloidal gold conjugate

• 關聯藥證數量: 1

Antibody/Substrate Reagent (1 x 25 mL) Contains monoclonal anti-acetaminophen antibody, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as preservative. Enzyme Conjugate Reagent (1 x 8 mL) Contains Acetaminophen labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative. Acetaminophen Calibrator Kit (1 x 5 mL, 5 x 2 mL) Contains 5 mL of negative calibrator and 2 mL each of 10, 25, 50, 100 and 200 μg/mL acetaminophen calibrators in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent 1 (9C309UL/9C329UL) 115mL/1000mL\n Mouse Monoclonal antibodies to d-amphetamine and d-methamphetamine, bovine serum albumin, G6P, NAD, preservative and stabilizers\n \n Enzyme Reagent 2 (9C309UL/9C329UL) 50mL/435mL\n Amphetamines labeled with baterial Tris buffer, bovine serum albumin, preservatives and stabilizers. \n\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent A (3 mL): sheep antibodies reactive to benzodiazepines (51 μg/mL), gIucose-6-phosphate (66 mM), nicotinamide adenine\ndinucleotide (40 mM), bulking agents, stabilizers, and preservatives.\n\nEnzyme Reagent B (3 mL): benzodiazepines labeled with bacterial glucose-6-phosphate dehydrogenase (0.48 U/mL), glucose-6-phosphate (32 mM), Tris buffer, bulking agents, stabilizers, and preservatives.\n\nEmit&reg; Drug Assay Buffer Concentrate (13.3 mL): Tris buffer, surfactant, and preservatives.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent(R1)：Contains monoclonal anti-MDMA antibody,glucose-6-phosphate(G6P), and nicotinamide adenine dinucleotide(NAD)in Tris buffer.\nEnzyme Conjugate Reagent(R2)：Contains MDMA labeled with glucose-6-phosphate dehydrogenase(G6PDH) in Tris buffer.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent. Contains mouse monoclonal anti-THC antibodies, glucose-6-phosphate, and nicotinamide adenine dinucleotide in Tris buffer.\nEnzyme Conjugate Reagent. Contains △9-THC labeled with glucose-6-phosphate dehydrogenase in Tris buffer.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent. \nContains monoclonal anti-primidone antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer.\nEnzyme Conjugate Reagent. Contains primidone derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer.

• 關聯藥證數量: 1

Antibody/Substrate Reagent. contains mouse monoclonal anti-benzoylecgonine antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer.\nEnzyme Conjugate reagent. Contains benzoylecgonine analog labeled with glucose-6-ohisohate dehydrogenase (G6PDH) in HEPES buffer.

• 關聯藥證數量: 1

Antibody/Substrate Reagent.Contains monoclonal anti-morphine antibody,glucose-6-phosphate and nicotinamide adenine dinucleotide.\nEnzyme Conjugate Reagent.Contains morphine labeled with glucose-6-phosphate dehydrogenase.

• 關聯藥證數量: 1

Antibody/Substrate Reagent.\nContains monoclonal anti-barbiturate antibody, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as preservative.\n\nEnzyme Conjugate Reagent.\nContains barbiturate labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as preservative.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69 mL (Monoclonal anti-bonzoylecgonine antibody (mouse)/Glucose-6-phosphate (G6P)/ Nicotinamide adenine dinucleotide (NAD)/Tris buffer) \nEnzyme Conjugate Reagent: 18 mL (Glucose-6-phosphate dehydrogenase (G6PDH) labeled with benzoylecgonine/ Tris buffer) \n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69 mL; Enzyme Conjugate Reagent: 18 mL

• 關聯藥證數量: 1

Antibody/Substrate Reagent: 69mL\nMonoclonal anti-Phencyclidine Antibody (mouse), Glucose-6-phosphate (G6P), Nicotinamide adenine dinucleotide (NAD), Tris buffer\nEnzyme Conjugate Reagent: 18mL\nGlucose-6-phosphate dehydrogenase(G6PDH) labeled with phencyclidine, Tris buffer\nAlso non-reactive chemicals necessary for optimal system performance\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains anti-barbiturate antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains barbituric acid derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains anti-benzodiazepine antibodies, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains benzodiazepine derivative labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-amphetamines antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.Enzyme Conjugate Reagent: Contains amphetamines labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-methadone antibody, glucose-6-phosphate, and nicotinamide adenine dinucleotide.\nEnzyme Conjugate Reagent: Contains methadone derivative labeled with glucose-6-phosphate dehydrogenase .

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-methaqualone antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine nucleotide (NAD) in Tris buffer withsodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains methaqualone labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent: Contains monoclonal anti-phencyclidine antibodies, glucose-6-phosphate (G6P) and nicotinamide adenine nucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent: Contains phencyclidine labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent:69 mL\nMonoclonal anti-methaqualone antibodies (mouse)\nGlucose-6-phosphate (G6P)\nNicotinamide adenine dinucleotide (NAD)\nTris buffer\nEnzyme Conjugate Reagent 18 mL\nGlucose-6-phosphate dehydrogenase (G6PDH) labeled with methaqualone derivative \nTris buffer

• 關聯藥證數量: 1

Antibody/Substrate Reagent:\nContains monoclonal anti-tricyclics antibodies, glucose-6-phosphate (G6P), and nicotinamide adenine dinucleotide (NAD) in Tris buffer.\nEnzyme Conjugate Reagent:\nContains glucose-6-phosphate dehydrogenase (G6PDH) labeled with nortriptyline in Tris buffer.\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent：69 mL\n Monoclonal anti-methadone antibody (mous) \nGlucose-6-phosphate (G6P) \nNicotinamide adenine dinucleotide (NAD) \nTris buffer\nEnzyme Conjugate Reagent：18 mL \nGlucose-6-phosphate dehydrogenase (G6PDH) labeled with methadone derivative \nTris buffer

• 關聯藥證數量: 1

Antibody/Substrate Reagent：69 mL\nPolyclonal anti-benzodiazepines antibodies (goat)\nGlucose-6-phosphate (G6P)\nNicotinamide adenine dinucleotide (NAD)\nTris buffer\nEnzyme Conjugate Reagent：18 mL \nGlucose-6-phosphate dehydrogenase (G6PDH) labeled with benzodiazepine analog derivative \nTris buffer\nβ-glucuronidase (E. coli) 4 mL\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent：69mL\nPolyclonal anti-benzodiazepines antibodies(goat)\nGlucose-6-phosphate(G6P)\nNicotinamide adenine dinucleotide(NAD)\nTris buffer\nEnzyme Conjugate Reagent：18 mL\nGlucose-6-phosphate dehydrogenase(G6PDH)labeled with benzodiazepine analog derivative\nTris buffer\n

• 關聯藥證數量: 1

Antibody/Substrate Reagent：Contains monoclonal anti-propoxyphene antibodies, glucose-6-phosphate(G6P) and nicotinamideadenine dinucleotide(NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent：Contains propoxyphene derivative labeled with glucose-6-phosphate dehydrogenase(G6PDH) in Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Antibody/Substrate Reagent：Contains monoclonal anti-thyroxine antibody,glucose-6-phosphate(G6P),and nicotinamide adenine dinucleotide(NAD)\nEnzyme Conjugate Reagent：Contains thyroxine and thyroxine-labeled glucose-6-phosphate dehydrogenase(G6PDH)

• 關聯藥證數量: 1

Antibody/Substrate Reagent：Contains mouse monoclonal anti-cotinine antibody, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in Tris buffer with sodium azide as a preservative.\nEnzyme Conjugate Reagent：Contains cotinine labeled with glucose-6-phosphate dehydrogenase (G6PDH) in Tris buffer with sodium azide as preservative.\nCotinine Low Control, 5 mL\nCotinine High Control, 5 mL\nCotinine Calibrator Kit, 6 x 5 mL

• 關聯藥證數量: 1

Antibody/substrate reagent1\nSheep polyclonal antibodies to benzoylecgonine. \nBovine Serum albumin.\nGlucose-6 phosphate (G6P).\nNicotianamide Adenine Dinucleotide (NAD).\nEnzyme Reagent 2\nBenzolyecgonine labeled with bacterial G6PDH. \nHEPES buffer.\nBovine serum albumin.

• 關聯藥證數量: 1

Antibody:1. Clone: 7T4-1F5、2. Hybridoma: NS-1 x BALB/c、3. Ig Chain: IgG2a、4. Species: Mouse、5. Purification: Affinity chromatography、6. Conjugation: FITC、MsIgG2a-FITC: nonantibody reagents: gelatin, potassium phosphate, NaCl, NaN3.

• 關聯藥證數量: 1

Antibody：Anti-human IgA antibody (goat polyclonal antibody)

• 關聯藥證數量: 1

Antigen Suclasses Quantity\nCoxsackie A9 IgG2b 1.0mL\nCoxsackie A24 IgG 1.0mL \n(Echovirus 34)\nCoxsackie B1 IgG2a 1.0mL\nCoxsackie B2 IgG2a 1.0mL\nCoxsackie B3 IgG2a 1.0mL\nCoxsackie B4 IgG2b 1.0mL\nCoxsackie B5 IgG2a 1.0mL\nCoxsackie B6 IgG2a 1.0mL\nCoxsackie B IgG2a 2.0mL\nBlend & IgG2b\nPrediluted Ready to UseMAB. \n

• 關聯藥證數量: 1

Antigen Coated Microwell strips: 8 wells x 12 strips; sample diluent: 100 mL; enzyme antibody reagent-human IgG heavy and light chain specific: 6 mL; substrate solution: containing TMB and H2O2, 6 mL; stopping reagent: 6 mL hydrochloric and sulfuric acid (<3%); ANA calibrator serum: 1 mL human serum with 0.1% sodium azide; ANA positive control: 1 mL human serum with 0.1% sodium azide; ANA negative control: 1 mL human serum with 0.1% sodium azide

• 關聯藥證數量: 1

Antigen Control Slides-10 slides: wight-well antigen control slides with one well each of (I) adenovirus, (II) A549 cell control, (III) influenza A, (IV) influenza B, (V) parainfluenza type 1, (VI) parainfluenza type 2, (VII) parainfluenza type 3, and (VIII) RSV have been provided as reagent staining controls.

• 關聯藥證數量: 1

Antigen Control Slide、\nMonoclonal Antibodies、\nRespiratory viral Screen、\nNormal Mouse Antibody、\nAnti-Mouse IgG: FITC Conjugate、\nPBS、\nTween 20/Sodium Azide Soution (100X)、\nMounting Fluid.

• 關聯藥證數量: 1

Antigen reagent:\nSuspension of sensitized chicken erythrocytes.\nControl reagent:\nSuspension of unsensitized chicken erythrocytes.\nDiluent solution:\nPhosphate buffered saline solution containing soluble components of T. Reiter and stabilizing agents.\nPositive control:\nImmune rabbit serum.\nNegative control:\nNormal rabbit serum.\nAll reagents contain <0.1% sodium azide.\n

• 關聯藥證數量: 1

Antigen/Control antigen \nlyophilized, reconstitute with distilled water as indicated on the label\nPositive and negative control sera\nlyophilized, reconstitute in 0.1ml distilled water.

• 關聯藥證數量: 1

Antimicrobial Agent Abbr.：\nAmikacin, Ampicillin, Ampicillin/Sulbactam, Aztreonam, Cefazolin, Cefepime, Cefotaxime, Cefotaxime/K Clavulanate, Cefotetan, Ceftazidime, Ceftazidime/K Clavulanate, Ceftriaxone, Cefuroxime, Ciprofloxacin, Gentamicin, Imipenem, Levofloxacin, Meropenem, Moxifloxacin, Piperacillin/Tazobactam, Ticarcillin/K Clavulanate, Tobramycin, Trimethoprim/Sulfamethoxazole

• 關聯藥證數量: 1

Antimicrobial Agents Abbr. [μg/ml*]\n1. Ampicillin Am 0.06-4\n2. Augmentin Aug 0.5/0.25-4/2\n3. Azithromycin Azi 0.25-2\n4. Chloramphenicol C 1-16\n5. Ceftriaxone Cax 0.25-2\n6. Clindamycin Cd 0.06-0.5\n7. Cefaclor Cfr 0.5-4\n8. Cefotaxime Cft 0.25-2\n9. Cefepime Cpe 0.25-2\n10. Cefuroxime Crm 0.25-2\n11. Erythromycin E 0.06-0.5\n12. Gatifloxacin Gat 0.12-2\n13. Levofloxacin Lvx 0.25-4\n14. Meropenem Mer 0.06-0.5\n15. Penicillin P 0.03-4\n16. Trimethoprim/ Sulfamethoxazole T/S 0.25/4.75-2/38\n17. Tetracycline Te 0.5-4\n18. Vancomycin Va 0.12-1\n* After rehydration with 115 μl\n

• 關聯藥證數量: 1

Antimicrobial Agents Abbr. [μg/ml*]\n1. Aztreonam Azt 0.5-64\n2. Cefepime Cpe 1-32\n3. Cefotaxime Cft 0.5-128\n4. Cefotaxime/ K Clavulanate Cft/CA 0.12/4-16/4\n5. Cefotetan Ctn 1-32\n6. Cefoxitin Cfx 2-32\n7. Cefpodoxime Cpd 0.5-64\n8. Ceftazidime Caz 0.5-128\n9. Ceftazidime/ K Clavulanate Caz/CA 0.12/4-16/4\n10. Ceftriaxone Cax 1-64\n11. Imipenem Imp 0.5-16\n12. Meropenem Mer 0.5-16\n13. Piperacillin Pi 16-64\n* After rehydration with 115 μl. \n

• 關聯藥證數量: 1

Antimicrobial Agents [μg/ml*]\n1. Amikacin 16-32\n2. Amoxicillin/K Clavulanate 8/4-16/8\n3. Ampicillin 8-16\n4. Ampicillin/Sulbactam 8/4-16/8\n5. Aztreonam 8-16\n6. Cefazolin 8-16\n7. Cefepime 8-16\n8. Cefotaxime 2, 8-32\n9. Cefotaxime/K Clavulanate 0.5/4, 4/4\n10. Cefoxitin 8-16\n11. Ceftazidime 1, 4-16\n12. Ceftazidime/K Clavulanate 0.25/4, 2/4\n13. Ceftriaxone 8, 32\n14. Cefuroxime 4-16\n15. Cephalothin 8-16\n16. Ciprofloxacin 1-2\n17. Ertapenem 1-4\n18. Gentamicin 4-8\n19. Imipenem 4-8\n20. Levofloxacin 2-4\n21. Meropenem 4-8\n22. Nitrofurantoin 32-64\n23. Piperacillin 16-64\n24. Piperacillin/Tazobactam 16, 64\n25. Tetracycline 4-8\n26. Tigecycline 2-4\n27. Tobramycin 4-8\n28. Trimethoprim/ Sulfamethoxazole 2/38\n* After rehydration with 115 μl. \n

• 關聯藥證數量: 1

Antimicrobial Agents: Amoxicillin/K Clavulanate 4/2μg/ml, Ampicillin 2-8μg/ml, Ampicillin/Sulbactam 8/4-16/8μg/ml, Cefoxitin Screen Well 4μg/ml, Ceftriaxone 8, 32μg/ml, Ciprofloxacin 1-2μg/ml, Clindamycin 0.5-4μg/ml, Daptomycin 0.5-4μg/ml, Erythromycin 0.5-4μg/ml, Gentamicin 4-8μg/ml, Gentamicin Synergy Screen 500μg/ml, Inducible Clindamycin Test 4/0.5μg/ml, Levofloxacin 1-4μg/ml, Linezolid 1-4μg/ml, Moxifloxacin 0.5-4μg/ml, Nitrofurantoin 32-64μg/ml, Oxacillin 0.25-2μg/ml, Penicillin 0.03, 0.12-0.25, 2, 8μg/ml, Rifampin 1-2μg/ml, Streptomycin Synergy Screen 1000μg/ml, Synercid 0.5-2μg/ml, Tetracycline 4-8μg/ml, Trimethoprim/Sulfamethoxazole 0.5/9.5-2/38μg/ml, Vancomycin 0.25-16μg/ml\nIdentification Substrates: Crystal Violet, Micrococcus Screen, Nitrate, Novobiocin, PNP-β-D-Glucuronide, Indoxyl Phosphatase, Voges-Proskauer, Optochin, Phosphatase, 40% Bile Esculin, L-Pyrrolidonyl-β-naphthylamide, Arginine, PNP-β-D-Galactopyranoside, Urea, Mannitol, Lactose, Trehalose, Mannose, Sodium Chloride 6.5%, Sorbital,

• 關聯藥證數量: 1

Antimicrobial agents (μg/mL)：\nAmikacin 16-32, Amoxicillin/K Clavulanate 8/4-16/8, Ampicillin 2-16, Aztreonam 8-16, Cefepime 8-16, Cefotaxime 2,8-32, Cefotaxime/ K Clavulanate 0.5/4, 4/4, Cefoxitin 8-16, Ceftazidime 2-16, Ceftazidime (ESBL Confirmation) 1,8, Ceftazidime/ K Clavulanate 0.25/4, 2/4, Ceftriaxone 8,32, Cefuroxime 4-16, Ciprofloxacin 1-2, Gatifloxacin 2-4, Gentamicin 2-8, Imipenem 4-8, Levofloxacin 2-4, Nitrofurantoin 32-64, Piperacillin/Tazobactam 16/4, 64/4, Ticarcillin/K Clavulanate 16/2, 64/2, Tobramycin 2-8, Trimethoprim/ Sulfamethoxazole 2/38

• 關聯藥證數量: 1

Antimicrobic: Cefepime, Cefotaxime, Chloramphenicol, Clindamycin, Erythromycin, Levofloxacin, Linezolid, Meropenem, Moxifloxacin, Penicillin, Quinupristin/dalfopristin, Teicoplanin, Telithromycin, Tetracycline, Trimethoprim/Sulfamethoxazole, Vancomycin\nBroth: Phoenix AST-S Broth 29.2g; Thymidine Phosphorylase 100 IU; Polysorbate 80 0.1g\nIndicator Solution: Redox indicator, less than 1.5g; Redox stabilizer, less than 20g 處方變更為:空白

• 關聯藥證數量: 1

Antimony Potassium Tartrate contains not less than 99.0% and not more than 103.0% of C8H4K2O12SB2・3H2O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Antsense Control (N) III：D-glucose 0.12%\nAntsense Control (H) III：D-glucose 0.4%\nAntsense Control (L) III：D-glucose 0.04%\nAntsense Calibrator III：D-glucose 0.15%

• 關聯藥證數量: 1

Apis mellifera, Vespula spp. Dolichovespula maculata \nPolistes spp. Dolichovespula arenaria Blatella germanica Aedes communis Chironomus thummi(C. riparius) Vespa crabro Solenopsis invicta \nCladotanytarsus Lewisi Trogoderma angustum (Solier) \nBombyx mori Gasterophilus intestinalis Tabanus spp.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0 % and not more than 102.0 % of C25H25N5O4, calculated on dried substance.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0% W/W and not more than 102.0% of C25H25N5O4 calculated on a dry basis.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0% and not more than 102.0% of C25H25N5O4, calculated on anhydrous basis.

• 關聯藥證數量: 1

Apixaban contains not less than 98.0% and not more than 102.0% of C25H25N5O4, calculated on dried basis.

• 關聯藥證數量: 1

Apo B Auto？N Daiichi\nBuffer Solution: Tri buffer (pH7.2) 100mmol/L\nMACROGOL 4000\nAntibody: antihuman apolipoprotein B\npolyclonal antibody(from goat) 10U/mL\nApo B Auto？N Daiichi Calibrator:\nHuman Serum

• 關聯藥證數量: 1

Apo C-II Auto？N Daiichi\nBuffer\nAntibody\nApo Auto？N High Calib CE：Serum、內含五種不同濃度ApoC.

• 關聯藥證數量: 1

Apo C-III Auto N DAIICHI 1：\nTris buffer (pH8.5) 100mmol/L\nMACROGOL\nApo C-III Auto N DAIICHI 2：\nantihuman apolipoprotein C-III polyclonal antibody 10U/mL\nbuffer

• 關聯藥證數量: 1

Apo E Auto．N”DAIICHI”(1) \nTris buffer (pH8.5) 100mmol/L\nMACROGOL\nApo E Auto．N”DAIICHI” (2)\nantihuman apolipoprotein E polyclonal antibody 10U/mL\nbuffer\n \n

• 關聯藥證數量: 1

ApoB Reagent containing:\nReactive IngredientsReagent 1 (R1): NoneReagent 2 (R2): Goat antisera to human apolipoprotein B Other IngredientsReagent 1 (R1): Preservative, polymer, buffer, inorganic salt Reagent 2 (R2): Preservative, buffer, inorganic salt Calibrator Kit 22 containing: CAL1-5, 0.5 mL each.ApoB Performance Verifiers I: containing 6 vials, 0.5 mL each.

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified Water Pancreatic Digest of Casein 7.5g Selected Meat Peptone 7.5g Corn Starch 1.0g Dipotassium Phosphate 4.0g Monopotassium Phosphate 1.0g Sodium Chloride 5.0g Agar 12.0g Hemoglobin 10.0g IsoVitaleX Enrichment 10.0 mL V-C-N Inhibitor 10.0 mL Trimethoprim Lactate 5.0mg

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified WaterPancreatic Digest of Casein…………………………………..7.5 gSelected Meat Peptone………………………………………..7.5 gCorn Starch……………………………………………………1.0 gDipotassium Phosphate……………………………………….4.0 gMonopotassium Phosphate……………………………………1.0 gSodium Chloride………………………………………………5.0 gAgar…………………………………………………………..12.0 gHemoglobin…………………………………………………..10.0 gIsoVitaleX Enrichment……………………………………….10.0 mL

• 關聯藥證數量: 1

Approximate Formula Per Liter Purified Water\nChromopeptone 10.0g\nGlucose 20.0g\nChromogen Mix 2.0g\nChloramphenicol 0.5g\nAgar 15.0g

• 關聯藥證數量: 1

Approximate Formula* Per 600 ml Purified Water: 2.5g Monopotassium Phosphate, 0.24 g Magensium Sulfate, 0.6 g \nSodium Citrate, 3.6 g L-Asparagine, 30.0 g Potato Flour, 0.4 g Malachite Green, 12.0 ml Glycerol, 1000.0 ml Whole egg.\n

• 關聯藥證數量: 1

Approximate Formula*Per Liter\nYeast Extract 10.0g\nFerric Pyrophosphate 0.25g\nACES Buffer 10.0g\nCharcoal, Activated 2.0g\nAlpha-Ketoglutarate 1.0g\nAgar 15.0g

• 關聯藥證數量: 1

Aprepitant contains not less than 98.0% and not more than 102.0% of C23H21F7N4O3, calculated on anhydrous substance.

• 關聯藥證數量: 1

Aqueous buffer solution containing ammonia, ethanol and sodium bicarbonate and Preservatives

• 關聯藥證數量: 1

Arachidonic Acid, 3 x 0.5 ml

• 關聯藥證數量: 1

Architect Anti-HBe Reagent,100 or 400 Tests Architect Anti-HBe Reagent Kit ．Microparticles 1 or 4 bottle(s) (6.6ml) Microparticles:Antibody to Hepatitis B e Antigen (mouse, monoclonal) coated microparticles in phosphate buffer with protein stabilizer. Minimum concentration:0.08% solids. Preservatives:ProClin 300 and other antimicrobial Agents. ．Conjugate 1 or 4 bottle(s) (5.9ml) Conjugate: Acridinium-labeled antibody to Hepatitis B e Antigen (mouse, monoclonal) conjugate in MES buffer with protein stabilizer. Minimum concentration:0.08 μg/ml. Preservative:ProClin 300. ．Neutralizing reagent 1 or 4 bottle(s) (5.9ml) Neutralizing Reagent:Hepatitis B e Antigen (recombinant DNA) in TRIS buffer with protein stabilizer. Minimum concentration:6.7 PEI U/ml. Preservatives:Antimicrobial Agents. Architect HBeAg Controls ．2 bottles (8ml each) of ARCHITECT Anti-HBe are recalcified human plasma. Archi

• 關聯藥證數量: 1

Architect Anti-HCV Reagent Kit1.1 or 4 Bottle(s) (6.6ml per 100 test bottle /27.0ml per 500 test bottle) HCV (E.coli, Yeast, Recombinant) antigen coated microparticles In MES buffer. Minimum concentration:0.14% solids.2.1 or 4 Bottle(s) (5.9ml per 100 test bottle /26.3ml per 500 test bottle) conjugate:Murine anti-IgG/anti-IgM acridinium labeled conjugate in MES buffer. Minimum concentration: (IgG) 8ng/ml (IgM) 0.8 ng/ml3.1 or 4 Bottle(s) (10.0ml per 100 test bottle/50.9ml per 500 test bottle) anti-HCV assay diluent containing TRIS buffer with protein stabilizer.Architect I Pre-Trigger Solution:Pre-Trigger solution containing1. 32% (W/V) hydrogen peroxide.Architect I Trigger Solution:Trigger solution containing 0.35 NSodium hydroxide.Architect I Wash Buffer:Wash buffer containing phosphate bufferedSaline solution.Architect Anti-HCV Calibrators:1 bottle (4ml each) of ArchitectAnti-HCV calibrator is prepared in recalcified human plasma(inactivated);reactive for a

• 關聯藥證數量: 1

Architect HBeAg Reagent Kit, 100 or 400 Tests Architect HBeAg Reagent Kit ．Microparticles 1 or 4 bottle(s) (6.6ml) Microparticles:Antibody to Hepatitis B e Antigen coated microparticles. ．Conjugate 1 or 4 bottle(s) (5.9ml) Conjugate: Acridinium-labeled antibody to Hepatitis B e Antigen conjugate. ．Assay Diluent 1 or 4 bottle(s) (3.9ml) Assay Diluent:Phosphate buffer with recalcified human plasma. Architect HBeAg Controls ．1 bottle (8ml) of Architect HBeAg Negative Control. ．1 bottle (8ml) of Architect HBeAg Positive Control. Architect HBeAg Calibrator ．1 bottle (4ml) of Calibrator 1 ．1 bottle (4ml) of Calibrator 2 Other solutions 1.Architect Pre-Trigger Solution 2.Architect Trigger Solution 3.Architect Wash buffer

• 關聯藥證數量: 1

Architect HBsAg Reagent Kit1.1 or 4 Bottle(s) (6.6ml per 100 test bottle /27.0ml per 500 test bottle) Anti-HBs (Mouse, Monoclonal IgM, IgG) Coated microparticles in MES buffer with protein stabilizers. Minimum Concentration:0.0675% solids.2.1 or 4 Bottle(s) (5.9ml per 100 tese bottle /26.3ml per 500 test bottle) Conjugate:Anti- HBs (Goat, IgG) Acridinium-LabeledConjugate in MES buffer with protein stabilizersMinimum concentration:0.25u g/mlArchitect HBsAg Manual Diluent:1 Bottle (100ml) Architect HBsAgManual diluent containing recalcified human plasma, nonreactiveFor HBsAg, HIV-1 Ag, anti-HIV-1/HIV-2, and anti-HBs.Architect i Pre-Trigger Solution:Pre-Trigger solution containing1.32% (W/V) hydrogen peroxide.Architect i Trigger Solution: Trigger solution containing 0.35NSodium hydroxide. Architect i wash buffer:Wash buffer containing phosphate bufferedSaline solution. Preservatives:Antimicrobial agent.Architect HBsAg calibrators:2 bottles (4ml each) of Architec

• 關聯藥證數量: 1

Arginine (L-Arginine) contains not less than 98.5% and not more than 101.0% of C6H14N4O2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Arginine hydrochloride (L-Arginine Monohydrochloride) contains not less than 98.5% and not more than 101.0% of (C6H14N4O2-HCl), calculated with reference to the dried substance.

• 關聯藥證數量: 1

Aripiprazole (On Dried Basis,) Not less than 98.0% and not more than 102.0%w/w

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2, calculated on the dried substance.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2,calculated on the dried basis.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.0% and not more than 102.0% of C23H27Cl2N3O2.

• 關聯藥證數量: 1

Aripiprazole contains not less than 98.5% and not more than 101% of C23H27Cl2N3O2, calculated on the dried basis.

• 關聯藥證數量: 1

Array Lipoprotein (a) Reagent:\nLPA Antibody\n(polyclonal anti-lipoprotein(a) antibody; rabbit 5.0 mL per vial.\nLipoprotein(a) Calibrator (LPA CAL):\nFresh frozen human plasma that has been defibrinated and processed, 1.0 mL per vial.\n

• 關聯藥證數量: 1

Arsenazo III 0.136 mmol/L\nSodium Azide 0.05%\nBuffer\nSurfactant

• 關聯藥證數量: 1

Arsenazo III 0.136 mmol/L\nSodium azide 0.05%

• 關聯藥證數量: 1

Arsenazo III：0.17 mmol/L

• 關聯藥證數量: 1

Articaine hydrochloride Assay (Titration, wt%): 98.5 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

Ascensia Elite Blood Glucose Test Strips: 29.1% w/w glucose oxidase (Aspergillus niger, 20 U/mg), 32.0% w/w potassium hexacyanoferrate (III), 38.9% w/w nonreactive ingredients \nAscensia Elite Control Solutions: glucose (% w/w) 0.07 (low), 0.10 (normal), 0.25 (high)

• 關聯藥證數量: 1